跳至主要内容
临床试验/NCT05791110
NCT05791110已完成不适用

Diagnostic Value of Fecal Pancreatic Elastase 1 in the Diagnosis of Pancreatic Exocrine Insufficiency: a Multi-center Study

Changhai Hospital1 个研究点 分布在 1 个国家目标入组 1,053 人开始时间: 2020年7月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,053
试验地点
1
主要终点
Reliability of fecal pancreatic elastase 1 test in the diagnosis of PEI

研究概览

简要总结

The aim of this study was to evaluate and determine the clinical performance of Fecal Pancreatic Elastase 1 Test in the diagnosis of pancreatic exocrine insufficiency.

详细描述

Fecal Pancreatic Elastase 1 (PE-1)Test has high diagnostic accuracy in pancreatic exocrine insufficiency (PEI), has become a painless noninvasive diagnostic modality in clinical practice, and has been widely used in clinical practice.

However, in China, the diagnostic ability of the PE-1 test in the Chinese population has not been demonstrated and has not been reported. Meanwhile, pancreatin stimulation, 13C-mixed triglyceride breath test, and N-benzoyl-L-tyrosyl-p-aminobenzoic acid test required drugs, which cannot pass the examination of the drug administration and were not allowed to be carried out to diagnose PEI in China. In addition pancreatin stimulation is an invasive test has certain risks for subjects and 72-hour fecal fat quantification was mainly used for the diagnosis of severe PEI. Therefore, This study adopted strict clinical diagnosis as a comparative method for PE-1 test to judge the ability of PE-1 test to diagnose PEI in the Chinese population.

This study aims to clarify the application efficacy of PE-1 test in PEI through a multi-center, prospective clinical study comparing PE-1 test with strict clinical diagnosis. To study the accuracy of PE-1 test in the diagnosis of PEI.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 【patients with clinical diagnosed PEI】
  • Inpatients or outpatients of both sexes, aged 18 to 80 years.
  • Patients with pancreatic disease or after pancreatic or gastric resection (one of the following)
  • Chronic pancreatitis.
  • At least 3 months after pancreatectomy (surgical procedures included total pancreatectomy, pancreaticoduodenectomy, pylorus-preserving pancreaticoduodenectomy, and distal pancreatectomy).
  • Patients recovering from severe acute pancreatitis (duration less than 24 months).
  • More than 3 months after gastrectomy (surgical methods included total gastrectomy, proximal gastrectomy, and distal gastrectomy).
  • Enrolled patients had at least one of the following symptoms (except those after pancreatectomy)
  • abdominal distension.
  • Weight loss (weight loss is defined as loss of more than 5% of basal body weight in one year).
  • steatorrhea.
  • Agreed to participate in the study and signed an informed consent form.
  • 【patients without clinical diagnosed PEI】
  • Both male and female, aged between 18 and 80 years old.
  • Patients who met one of the following criteria were included in the study:
  • Patients with functional gastrointestinal diseases who had no history of pancreatectomy, gastrectomy, or abdominal radiotherapy were included.
  • Healthy volunteers.
  • Patients with benign hepatobiliary diseases, thyroid, breast diseases, and digestive tract diseases who had no history of pancreatectomy, gastrectomy, or abdominal radiotherapy were included.
  • Agreed to participate in the study and signed an informed consent form.

排除标准

  • Pregnant women
  • Critically ill patients
  • The subjects with mental disorders were unable to cooperate with the researchers
  • patients who had undergone ileocolon bladder replacement surgery or complicated with intestinal obstruction and other diseases that could not collect feces
  • the quantity of fecal samples, storage and transportation conditions of samples do not meet the requirements of the kit
  • patients who underwent two or more times of gastrectomy or pancreatectomy

结局指标

主要结局

Reliability of fecal pancreatic elastase 1 test in the diagnosis of PEI

时间窗: 1 week

Diagnostic consistency (kappa value) of fecal pancreatic elastase 1 test

次要结局

  • Predictive value of fecal pancreatic elastase 1 test in the diagnosis of PEI(1 week)
  • Accuracy of fecal pancreatic elastase 1 test in the diagnosis of PEI(1 week)
  • Accuracy, reliability, and predictive of fecal pancreatic elastase 1 test in the diagnosis of severe PEI(1 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhuan Liao

Professor

Changhai Hospital

研究点 (1)

Loading locations...

相似试验